Charles River Laboratories (United States)
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Charles River Laboratories (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
2.1K
Total Open
Publications
1.1K
Total
Citations
31K
Open Access
Percentage
53%
Total
Publications
2.1K
Total Open
Publications
1.1K
Total
Citations
31K
Breakdown
Publisher Open
27%
Both
18%
Other Platform Open
8%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
217
Hybrid 29%
277
No Guarantees 48%
458
Other Platform Open
Domain 79%
451
Institution 25%
141
Preprint 13%
74
Public 8%
47
Other Internet 7%
39
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 447 |
Europe PMC | Domain | 238 |
bioRxiv | Preprint | 39 |
Semantic Scholar | Public | 36 |
DOI | Other Internet | 21 |
University College London - UCL Discovery | Institution | 19 |
University of Dundee - Discovery Research Portal | Institution | 14 |
Research Square | Preprint | 14 |
University of Cambridge - Apollo | Institution | 13 |
Radboud University - Radboud Repository | Institution | 13 |